US 12,434,052 B2
Breathable pad generating tumor treating field and methods of production and use thereof
Richard Deslauriers, Woodbury, CT (US)
Assigned to Novocure GMBH, Root (CH)
Filed by Novocure GmbH, Root (CH)
Filed on Nov. 16, 2023, as Appl. No. 18/511,679.
Application 18/511,679 is a continuation of application No. 17/313,114, filed on May 6, 2021.
Claims priority of provisional application 63/141,315, filed on Jan. 25, 2021.
Claims priority of provisional application 63/128,276, filed on Dec. 21, 2020.
Claims priority of provisional application 63/085,476, filed on Sep. 30, 2020.
Claims priority of provisional application 63/068,213, filed on Aug. 20, 2020.
Claims priority of provisional application 63/061,316, filed on Aug. 5, 2020.
Claims priority of provisional application 63/061,419, filed on Aug. 5, 2020.
Claims priority of provisional application 63/046,364, filed on Jun. 30, 2020.
Claims priority of provisional application 63/030,138, filed on May 26, 2020.
Claims priority of provisional application 63/020,636, filed on May 6, 2020.
Prior Publication US 2024/0157134 A1, May 16, 2024
Int. Cl. A61N 1/36 (2006.01); A61N 1/04 (2006.01); A61N 1/40 (2006.01)
CPC A61N 1/36002 (2017.08) [A61N 1/0492 (2013.01); A61N 1/36034 (2017.08); A61N 1/40 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A system, comprising:
a generator configured to generate an electrical signal having an alternating current waveform at a frequency in a range from 50 kHz to 500 kHz;
a first conductive lead electrically coupled to the generator, the first conductive lead configured to carry the electrical signal;
a first pad having a first electrode element directly connected to a first conductive gel element, the first conductive gel element is configured to be in contact with a patient's skin, the first electrode element and the first conductive gel element define at least one perforation extending through the first electrode element and the first conductive gel element;
a second conductive lead electrically coupled to the generator, the second conductive lead configured to carry the electrical signal; and
a second pad having a second electrode element directly connected to a second conductive gel element, and the second conductive gel element being configured to be in contact with a patient's skin.